Jump to main content
Jump to site search
PLANNED MAINTENANCE Close the message box

Scheduled maintenance work on Wednesday 27th March 2019 from 11:00 AM to 1:00 PM (GMT).

During this time our website performance may be temporarily affected. We apologise for any inconvenience this might cause and thank you for your patience.


Issue 45, 2018
Previous Article Next Article

Platelets and their biomimetics for regenerative medicine and cancer therapies

Author affiliations

Abstract

Platelets, circulating blood cells derived from megakaryocytes, play a key role in various physical activities, including coagulation, hemostasis, the body's innate immune response, and cancer metastasis. By taking advantage of their key traits, researchers have developed strategies to exploit platelets and platelet-mimicking nanoassemblies to treat a number of conditions, including wounds, cancers, and bacterial infections. Compared to traditional polymer, liposome, and inorganic nanoparticle-based delivery systems, platelets and platelet-mimicking vehicles hold many advantages. Among these are their enhanced circulation time, their large volumes and surface areas for drug loading or conjugation, and their inherent ability to target some diseases. In this review, we will highlight the recent progress made in the development of disease-targeting platelets and platelet-mimicking vehicles as therapeutic platforms.

Graphical abstract: Platelets and their biomimetics for regenerative medicine and cancer therapies

Back to tab navigation

Publication details

The article was received on 31 Aug 2018, accepted on 22 Oct 2018 and first published on 22 Oct 2018


Article type: Review Article
DOI: 10.1039/C8TB02301H
Citation: J. Mater. Chem. B, 2018,6, 7354-7365

  •   Request permissions

    Platelets and their biomimetics for regenerative medicine and cancer therapies

    Z. Li, S. Hu and K. Cheng, J. Mater. Chem. B, 2018, 6, 7354
    DOI: 10.1039/C8TB02301H

Search articles by author

Spotlight

Advertisements